Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe Record History now shows the platform revision updated to v3.6.4, replacing v3.6.3. This is a system update to the ClinicalTrials.gov interface and does not change the study data or its presentation beyond the version label.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe study record history now shows a new Revision: v3.6.3 entry and removes the previous Revision: v3.6.2 entry, reflecting an updated release in the history log.SummaryDifference0.1%

- Check34 days agoChange DetectedThe study record history now shows a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed, updating the version history.SummaryDifference0.1%

- Check48 days agoChange DetectedNew quick links 'Check who can join' and 'Find Contact Information' appear on the record history page, facilitating eligibility checks and contact access. The revision note now shows Revision: v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.5%

- Check55 days agoChange DetectedThe version history now shows a new release entry for v3.5.5, replacing the previous v3.5.4. This reflects a backend/UI update without changes to the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedThe Record History now includes a new Revision: v3.5.4 entry as part of the version history, and the previous Revision: v3.5.3 entry has been removed from the list. This reflects a minor site release update rather than any change to trial data or descriptions.SummaryDifference0.1%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.